RRB Staff Nurse Jaipur-6th June 2018
Pharmacology
Easy

Extra – pyramidal symptoms are side effects of

Appeared in: RRB Staff Nurse Jaipur-6th June 2018

Explanation

  • Extrapyramidal symptoms (EPS) are a well-known group of movement-related side effects caused by antipsychotic medications.
  • These drugs work by blocking dopamine D2 receptors. This blockade in the nigrostriatal pathway of the brain, which controls motor function, leads to the development of EPS.
  • First-generation (typical) antipsychotics have a higher affinity for D2 receptors and are therefore more likely to cause EPS than second-generation (atypical) antipsychotics.

Why Other Options Were Wrong

  • Option B: Antimanic agents, such as lithium, are not primarily associated with extrapyramidal symptoms. Their characteristic neurological side effect is a fine hand tremor.
  • Option C: Antidepressants, like SSRIs and TCAs, primarily act on serotonin and norepinephrine. While they can have neurological side effects, the classic EPS profile is not a characteristic or common one.
  • Option D: Anti-Parkinsonian agents are used to treat, not cause, extrapyramidal symptoms. They work by increasing dopamine levels or blocking acetylcholine to restore balance in the motor system.

Related Visual

Visual explanation — Related Visual
  • Visual 1: Chart - A chart listing the different types of Extrapyramidal Symptoms (dystonia, akathisia, parkinsonism, tardive dyskinesia) with their key signs and typical onset time after starting an antipsychotic.
  • Visual 2: Diagram - A simplified diagram of the brain showing the nigrostriatal dopamine pathway and illustrating how D2 receptor blockade by antipsychotics leads to movement side effects.
Clinical Relevance
  • Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacology: Side Effects of Antipsychotic Medications (Extrapyramidal Symptoms) as background academic context rather than a clinical decision trigger.
  • A crucial nursing responsibility is to monitor patients on antipsychotics for the emergence of EPS. Early identification and reporting can prevent significant distress and complications.
  • Nurses often administer medications like benztropine (Cogentin) or diphenhydramine (Benadryl) to manage acute dystonic reactions, which can be frightening for the patient.
  • The Abnormal Involuntary Movement Scale (AIMS) is a key assessment tool used by nurses to screen for and track the severity of tardive dyskinesia in patients on long-term antipsychotic therapy.
How to Approach the Question
  • First, identify the core concept in the question stem: 'Extra-pyramidal symptoms' (EPS). This is a specific term related to drug side effects.
  • Recognize this as a factual recall question from pharmacology. The goal is to link a specific side effect profile to a drug class.
  • Systematically review the options. Think about the primary mechanism and most famous side effects of each drug class.
  • Recall or deduce that 'antipsychotics' are known for blocking dopamine, a key neurotransmitter for motor control. This makes them the most likely cause of movement disorders like EPS.
  • Eliminate the other options. Anti-Parkinsonian agents do the opposite (increase dopamine activity), so they treat EPS. Antidepressants and antimanics have different primary side effect profiles.
Concept Tested & Keywords
  • Concept Tested: Pharmacology: Side Effects of Antipsychotic Medications (Extrapyramidal Symptoms)
  • Stem keywords: Extra – pyramidal symptoms, side effects
  • Lead-in keywords: are

Question ID

QeXbQFGcibv2RhI4g6yo0K

Practise the full RRB Staff Nurse Jaipur-6th June 2018

Attempt every question from this paper in a timed mock, then review the full solution for each one.